GLP-1 drug prescribed to woman with eating disorder via telehealth sparks calls for regulation
Health experts in Australia are calling for stricter regulation of telehealth clinics after a patient with a history of anorexia nervosa was prescribed weight-loss medication. The incident highlights concerns over the lack of oversight in online prescribing models for GLP-1 receptor agonists.
Why it matters
The rapid rise of telehealth weight-loss services has outpaced regulatory frameworks, creating potential risks for vulnerable patients with pre-existing mental health conditions.
Experts say telehealth prescribing might not be the best model for prescribing weight-loss medications. ( Getty Images: Tatsiana Volkava )
The article presents a balanced view by citing expert concerns while explaining the context of the telehealth industry and the benefits of the drugs.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in